0001161697-22-000556.txt : 20221122 0001161697-22-000556.hdr.sgml : 20221122 20221122170016 ACCESSION NUMBER: 0001161697-22-000556 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221118 FILED AS OF DATE: 20221122 DATE AS OF CHANGE: 20221122 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MCENANY PATRICK J CENTRAL INDEX KEY: 0000929985 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33057 FILM NUMBER: 221411287 MAIL ADDRESS: STREET 1: C/O THERMOGENESIS CORP STREET 2: 2711 CITRUS ROAD CITY: RANCHO CORDOVA STATE: CA ZIP: 95742 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CATALYST PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001369568 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 355 ALHAMBRA CIRCLE STREET 2: SUITE 801 CITY: CORAL GABLES STATE: FL ZIP: 33134 BUSINESS PHONE: (305) 529-2522 MAIL ADDRESS: STREET 1: 355 ALHAMBRA CIRCLE STREET 2: SUITE 801 CITY: CORAL GABLES STATE: FL ZIP: 33134 FORMER COMPANY: FORMER CONFORMED NAME: CATALYST PHARMACEUTICAL PARTNERS, INC. DATE OF NAME CHANGE: 20110215 FORMER COMPANY: FORMER CONFORMED NAME: Catalyst Pharmaceutical Partners, Inc. DATE OF NAME CHANGE: 20060719 4 1 form4.xml FORM 4 FOR 11-18-2022 X0306 4 2022-11-18 0 0001369568 CATALYST PHARMACEUTICALS, INC. CPRX 0000929985 MCENANY PATRICK J 355 ALHAMBRA CIRCLE, SUITE 801 CORAL GABLES FL 33134 1 1 0 0 President and CEO Common stock, par value $0.001 per share 2022-11-18 4 M 0 350000 2.24 A 4252606 D Common stock, par value $0.001 per share 2022-11-18 4 S 0 350000 15.622 D 3902606 D Common stock, par value $0.001 per share 2022-11-21 4 M 0 150000 2.24 A 4052606 D Common stock, par value $0.001 per share 2022-11-21 4 S 0 150000 15.332 D 3902606 D Options to purchase common stock 2.24 2022-11-18 4 M 0 350000 0 D 2025-12-19 Common Stock 350000 3015834 D Options to purchase common stock 2.24 2022-11-21 4 M 0 150000 0 D 2025-12-19 Common Stock 150000 2865834 D Shares were sold for personal reasons. Shares were not sold as a result of any disagreement with the Company and Mr. McEnany remains a director and an officer of the Company. Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $15.50 to $16.06 per share. Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $15.19 to $15.55 per share. Options vested in three equal tranches on December 19, 2019, 2020 and 2021. /s/ Patrick J. McEnany 2022-11-22